Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%

NCT02158013 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT02158013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02158013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%
Lead sponsor
Bispebjerg Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 1, 2014
Completion date
February 5, 2018
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic anal fissure